Beer D G, Pitot H C
Arch Toxicol Suppl. 1987;10:68-80. doi: 10.1007/978-3-642-71617-1_6.
The identification of biological "markers" indicating distinctively different functions between preneoplastic and neoplastic as compared with normal cells has been a subject of intensive investigation, especially as additional technology becomes available. Although no distinct single biochemical marker is ubiquitous to the process of neoplasia or even to a single histogenetic type of neoplasm, a variety of histogenetic types of neoplasms in the human and experimental animals exhibit an extreme degree of marker or phenotypic heterogeneity. Particularly well studied are markers which occurred during the process of hepatocarcinogenesis in the rodent as well as in its final product, the hepatoma. Although phenotypic heterogeneity is characteristic of hepatocellular carcinomas in both the rat and mouse, some degree of predominant marker pattern(s) has become apparent. In multistage hepatocarcinogenesis in the rat a frequent but not completely ubiquitous marker is the enzyme gamma-glutamyltranspeptidase. In the mouse, although such markers have not been as extensively studied as in the rat, glucose 6-phosphatase is a predominant but not exclusive histochemical marker. Many preneoplastic lesions occurring during the stage of promotion exhibit reduced levels of enzymes of oxidative xenobiotic metabolism, but this pattern is not ubiquitous. Studies on the transcription of specific genes in mouse liver as well as preneoplastic and neoplastic lesions in this tissue further demonstrate the phenotypic heterogeneity characteristic of differentiated hepatocellular carcinomas. In general, current evidence supports the two theses that no single biologic marker or set of markers is uniquely characteristic of the preneoplastical and/or neoplastic phenotype and marker or phenotypic heterogeneity is by far the rule rather than the exception in hepatocarcinogenesis in the rodent and quite possibly in all histogenetic types of neoplasms in mammals.
与正常细胞相比,识别表明癌前细胞和肿瘤细胞之间具有显著不同功能的生物学“标志物”一直是深入研究的课题,尤其是随着更多技术的出现。尽管没有独特的单一生化标志物在肿瘤形成过程中普遍存在,甚至在单一组织发生类型的肿瘤中也不存在,但人类和实验动物中多种组织发生类型的肿瘤表现出极高程度的标志物或表型异质性。在啮齿动物肝癌发生过程及其最终产物肝癌中出现的标志物得到了特别深入的研究。尽管表型异质性是大鼠和小鼠肝细胞癌的特征,但某种程度上占主导的标志物模式已变得明显。在大鼠的多阶段肝癌发生过程中,一种常见但并非完全普遍存在的标志物是γ-谷氨酰转肽酶。在小鼠中,尽管此类标志物的研究不如大鼠广泛,但葡萄糖6-磷酸酶是一种主要但并非唯一的组织化学标志物。在促进阶段出现的许多癌前病变表现出氧化异源生物代谢酶水平降低,但这种模式并不普遍。对小鼠肝脏以及该组织中的癌前病变和肿瘤病变中特定基因转录的研究进一步证明了分化型肝细胞癌的表型异质性特征。总体而言,目前的证据支持两个论点,即没有单一的生物标志物或一组标志物是癌前和/或肿瘤表型的独特特征,并且标志物或表型异质性在啮齿动物肝癌发生中是普遍规律而非例外,很可能在哺乳动物所有组织发生类型的肿瘤中也是如此。